Generation LNP Advancements enhance potency and safety, expand delivery beyond the liver, and enable broader therapeutic ...

A groundbreaking new trial is set to investigate whether an mRNA jab, designed to target the Epstein-Barr virus (EBV), could ...

At the conference, Acuitas' Chief Scientific Officer, Dr. Ying Tam, showcased the company's Next-Generation LNP advancements, a comprehensive approach that uses multiple technologies and strategies to ...

近日，智飞生物全资子公司安徽智飞龙科马自主研发的 带状疱疹mRNA疫苗临床试验申请正式获得国家药品监督管理局受理 ...

The U.S. Senate’s Permanent Subcommittee on Investigations held a crucial hearing titled "The Corruption of Science and ...

近年来，癌症“治疗性疫苗”成为全球肿瘤免疫治疗中增长最快的领域。我国自主研发的 新生抗原mRNA癌症疫苗LK101已获得了美国FDA临床试验批件 ，此外LK101也在多项临床研究中展现出可观的抗肿瘤活性。在2024年ASCO ...

In a surprising discovery, a "sticky molecule" that occurs naturally in our blood vessels could be both a culprit behind ...

Discover why Cartesian Therapeutics, Inc. earns a Buy rating with strong CAR-T pipeline progress and market growth in ...

The Senate Homeland Security and Governmental Affairs Committee held a powerful hearing on vaccine injury testimonies. Among ...

每经AI快讯，有投资者在投资者互动平台提问：董秘您好，公司与马来西亚政府合作开发多价mRNA流感疫苗进展如何？谢谢！

Berenberg lowered the firm’s price target on Moderna (MRNA) to $28 from $30 and keeps a Hold rating on the shares. The firm thinks BioNTech’s ...

Referencing the Charlie Kirk assassination, Wyoming GOP leaders passed a resolution Saturday in Torrington asking state ...